journal article·2020-09-30Open access

The Intracellular Number of Magnetic Nanoparticles Modulates the Apoptotic Death Pathway after Magnetic Hyperthermia Treatment

Lilianne Beola, Laura Asín, Catarina Roma-Rodrigues, Yilian Fernández-Afonso, Raluca M. Fratila, David Serantes, Sergiu Ruta, Roy W. Chantrell, Alexandra R. Fernandes, Pedro V. Baptista, Jesús M. de la Fuente, Valeria Grazú, Lucía Gutiérrez

ACS Applied Materials & Interfaces· Volume 12· Issue 39

Abstract

Magnetic hyperthermia is a cancer treatment based on the exposure of magnetic nanoparticles to an alternating magnetic field in order to generate local heat. In this work, 3D cell culture models were prepared to observe the effect that a different number of internalized particles had on the mechanisms of cell death triggered upon the magnetic hyperthermia treatment. Macrophages were selected by their high capacity to uptake nanoparticles. Intracellular nanoparticle concentrations up to 7.5 pg Fe/cell were measured both by elemental analysis and magnetic characterization techniques. Cell viability after the magnetic hyperthermia treatment was decreased to <25% for intracellular iron contents above 1 pg per cell. Theoretical calculations of the intracellular thermal effects that occurred during the alternating magnetic field application indicated a very low increase in the global cell temperature. Different apoptotic routes were triggered depending on the number of internalized particles. At low intracellular magnetic nanoparticle amounts (below 1 pg Fe/cell), the intrinsic route was the main mechanism to induce apoptosis, as observed by the high Bax/Bcl-2 mRNA ratio and low caspase-8 activity. In contrast, at higher concentrations of internalized magnetic nanoparticles (1-7.5 pg Fe/cell), the extrinsic route was observed through the increased activity of caspase-8. Nevertheless, both mechanisms may coexist at intermediate iron concentrations. Knowledge on the different mechanisms of cell death triggered after the magnetic hyperthermia treatment is fundamental to understand the biological events activated by this procedure and their role in its effectiveness.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Microbial Inactivation Methods · Endoplasmic Reticulum Stress and Disease · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain

Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 50009 Zaragoza, Spain

UCIBIO, Departamento de Cičncias da Vida, Faculdade de Cičncias e Tecnologia, Universidade Nova de Lisboa, Campus da Caparica, 2829-516 Caparica, Portugal

Applied Physics Department and Instituto de Investigacións Tecnolóxicas, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain

Department of Physics, University of York, Heslington, YO10 5DD York, United Kingdom

Department of Analytical Chemistry, Universidad de Zaragoza, Edificio I+D, 50018 Zaragoza, Spain

Funding

Universidad de Zaragoza · Ministerio de Ciencia, Innovaci?n y Universidades · European Commission · Ministerio de Econom?a, Industria y Competitividad, Gobierno de Espa?a · Xunta de Galicia · Funda??o para a Ci?ncia e a Tecnologia · Diputaci?n General de Arag?n

References (71)

Show source-provided references
1. 10.1016/j.jconrel.2016.05.06210.1016/j.jconrel.2016.05.062 ↗
2. 10.3109/02656736.2013.82299310.3109/02656736.2013.822993 ↗
3. 10.1002/ange.20130583510.1002/ange.201305835 ↗
4. 10.1021/nl400188q10.1021/nl400188q ↗
5. 10.1080/15567265.2015.103185710.1080/15567265.2015.1031857 ↗
6. 10.1016/j.nano.2020.10217110.1016/j.nano.2020.102171 ↗
7. 10.1038/cddis.2013.12110.1038/cddis.2013.121 ↗
8. 10.1007/s11095-012-0710-z10.1007/s11095-012-0710-z ↗
9. 10.1021/acsami.8b1827010.1021/acsami.8b18270 ↗
10. 10.1088/0957-4484/22/20/20510110.1088/0957-4484/22/20/205101 ↗
11. 10.2217/nnm.15.7010.2217/nnm.15.70 ↗
12. 10.1166/jbn.2019.281010.1166/jbn.2019.2810 ↗
13. 10.1186/s40580-018-0136-310.1186/s40580-018-0136-3 ↗
14. Raj D. B. T. G. · 2019 · 2125 · 16710.1007/7651_2019_212 ↗
15. 10.1016/j.biomaterials.2014.04.03610.1016/j.biomaterials.2014.04.036 ↗
16. 10.2217/nnm.13.20710.2217/nnm.13.207 ↗
17. 10.1021/nn201822b10.1021/nn201822b ↗
18. 10.2147/IJN.S1461310.2147/IJN.S14613 ↗
19. 10.1021/nn400704810.1021/nn4007048 ↗
20. 10.1016/j.jconrel.2017.11.05010.1016/j.jconrel.2017.11.050 ↗
21. 10.1038/sj.onc.120751210.1038/sj.onc.1207512 ↗
22. 10.1016/j.bbamcr.2008.09.00810.1016/j.bbamcr.2008.09.008 ↗
23. 10.1515/BC.2002.11210.1515/BC.2002.112 ↗
24. 10.2174/157341371266615112419584610.2174/1573413712666151124195846 ↗
25. Lee Y. · Yale J. Biol. Med. · 2019 · 92 · 687
26. 10.1080/2162402X.2015.107437810.1080/2162402X.2015.1074378 ↗
27. 10.1038/nri.2016.10710.1038/nri.2016.107 ↗
28. 10.1038/nmat302510.1038/nmat3025 ↗
29. 10.1021/nn204543c10.1021/nn204543c ↗
30. 10.1002/jcp.2016610.1002/jcp.20166 ↗
31. 10.1039/b708156a10.1039/b708156a ↗
32. 10.2217/nnm.15.18510.2217/nnm.15.185 ↗
33. 10.1016/j.matbio.2011.06.00110.1016/j.matbio.2011.06.001 ↗
34. 10.1016/j.biomaterials.2016.12.01910.1016/j.biomaterials.2016.12.019 ↗
35. 10.3390/ma1214221810.3390/ma12142218 ↗
36. 10.1038/nrurol.2016.23810.1038/nrurol.2016.238 ↗
37. 10.1016/S0959-8049(02)00210-110.1016/S0959-8049(02)00210-1 ↗
38. Netti P. A. · Cancer Res. · 2000 · 60 · 2497
39. 10.1002/jmri.188007062910.1002/jmri.1880070629 ↗
40. 10.1016/j.nano.2015.11.02010.1016/j.nano.2015.11.020 ↗
41. 10.1007/978-1-60327-017-5_210.1007/978-1-60327-017-5_2 ↗
42. 10.1016/j.biomaterials.2016.11.00810.1016/j.biomaterials.2016.11.008 ↗
43. 10.1021/acs.langmuir.5b0355910.1021/acs.langmuir.5b03559 ↗
44. 10.1063/1.348888110.1063/1.3488881 ↗
45. 10.1039/C7CP01442B10.1039/C7CP01442B ↗
46. 10.1021/acs.jpcc.5b0255510.1021/acs.jpcc.5b02555 ↗
47. 10.1002/adfm.20120030710.1002/adfm.201200307 ↗
48. 10.1038/srep0909010.1038/srep09090 ↗
49. 10.1063/1.482464910.1063/1.4824649 ↗
50. 10.1038/srep0165210.1038/srep01652 ↗
51. 10.1142/S233954781450019810.1142/S2339547814500198 ↗
52. 10.1021/nn503888j10.1021/nn503888j ↗
53. 10.1038/srep3992210.1038/srep39922 ↗
54. 10.1021/acsnano.7b0899510.1021/acsnano.7b08995 ↗
55. 10.1016/S0304-8853(98)00552-610.1016/S0304-8853(98)00552-6 ↗
56. 10.1039/C5SM00084J10.1039/C5SM00084J ↗
57. 10.1038/bjc.2016.11110.1038/bjc.2016.111 ↗
58. 10.7314/APJCP.2015.16.6.212910.7314/APJCP.2015.16.6.2129 ↗
59. 10.1007/s10495-009-0452-510.1007/s10495-009-0452-5 ↗
60. 10.1515/BC.2007.06410.1515/BC.2007.064 ↗
61. 10.1046/j.0022-202x.2001.01409.x10.1046/j.0022-202x.2001.01409.x ↗
62. 10.1016/j.actbio.2017.05.04710.1016/j.actbio.2017.05.047 ↗
63. 10.1021/acsami.9b0831810.1021/acsami.9b08318 ↗
64. 10.1021/acsnano.9b0806110.1021/acsnano.9b08061 ↗
65. 10.1073/pnas.181679211610.1073/pnas.1816792116 ↗
66. 10.1038/s41418-017-0012-410.1038/s41418-017-0012-4 ↗
67. 10.1103/PhysRevB.63.02441010.1103/PhysRevB.63.024410 ↗
68. Néel L. · Ann Géophys. · 1949 · 5 · 99
69. 10.1039/C5MB00791G10.1039/C5MB00791G ↗
70. 10.1002/chem.20180254710.1002/chem.201802547 ↗
71. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗